Hair Dye and Cancer Risk
Based on the most recent and comprehensive evidence, personal use of hair dye does not appear to cause a marked increase in overall cancer risk for most users, though specific populations may face modestly elevated risks for certain cancers.
Overall Cancer Risk Assessment
The highest quality recent evidence comes from a large prospective cohort study of 117,200 US women followed for 36 years 1. This study found no significant increases in risk of solid cancers overall or hematopoietic cancers overall among ever users of permanent hair dyes compared with non-users. Additionally, ever users did not have increased risk for most specific cancers including bladder cancer, melanoma, hormone receptor positive breast cancer, brain cancer, colorectal cancer, kidney cancer, or lung cancer 1.
A comprehensive 2026 systematic review examining studies from 1964-2025 similarly concluded that while some studies suggest potential associations, the evidence indicates possible increased cancer risks primarily for frequent, long-term hair dye use in specific populations 2.
Specific Cancers with Elevated Risk
Modest Risk Increases
Several cancers show small but statistically significant associations:
Basal cell carcinoma: Slightly increased risk (5% increase) among ever users, with higher risk observed specifically in women with naturally light hair 1
Hormone receptor negative breast cancer: Cumulative dose was positively associated with estrogen receptor negative, progesterone receptor negative, and hormone receptor negative breast cancer 1
Ovarian cancer: Positive association with cumulative dose 1
Hematopoietic cancers: A meta-analysis found a pooled relative risk of 1.15 (15% increase) for hematopoietic cancers 3, with lymphoma risk increased by 19% overall and 26% among persons using dyes 12+ times per year 4
Bladder Cancer - Conflicting Evidence
The evidence for bladder cancer is mixed. While the large prospective cohort found no increased risk 1, a meta-analysis of sensitivity analyses suggested personal use increases bladder cancer risk by 22-50% when accounting for confounding factors 5. A recent US case-control study reported positive associations with cumulative THM intake 2.
High-Risk Populations
By Race/Ethnicity
- African American women: Increased risk of estrogen receptor positive breast cancer 2
By Genetic Factors
- Slow acetylator N-acetyltransferase 2 (NAT2) genotypes: Elevated cancer risk with dye use 2
- CYP1A2 genetic variants: Elevated cancer risk with dye use 2
By Timing of Use
- Pre-1980 users: Significantly higher lymphoma risk among persons who started coloring hair before 1980 (37% increase) or used dyes only before 1980 (62% increase) 4. This likely reflects changes in dye formulations over time, with older products containing more carcinogenic compounds.
Maternal and Pediatric Risk
- Maternal use during first trimester: Significantly increased offspring risk of acute lymphoblastic leukemia, further elevated by continued use during lactation 2
Clinical Recommendations
For average-risk patients: Reassure that personal hair dye use does not substantially increase overall cancer risk. No specific screening modifications are warranted based solely on hair dye use.
For high-risk populations (African American women, those with NAT2 or CYP1A2 variants, frequent users):
- Counsel about modestly elevated risks for specific cancers
- Consider limiting frequency of use (avoid >12 applications per year)
- Discuss alternative hair coloring methods if concerned
For pregnant women: Advise avoiding hair dye use during first trimester and lactation given the association with childhood leukemia risk in offspring 2.
For all users: Modern formulations (post-1980) appear safer than older products, though long-term, frequent use still warrants caution 4.
Important Caveats
The carcinogenic potential appears related to redox mechanisms of major hair dye components 6, and interindividual genetic variation in enzymes handling these xenobiotics explains why some individuals are more susceptible 6. The concentration of metals in tattoo ink (which shares some chemical similarities) is noted as an emerging concern for carcinogenicity 7, suggesting cumulative lifetime exposure matters.
The evidence does not support avoiding hair dye entirely for most people, but frequent, long-term users—particularly those in high-risk groups—should be counseled about potential modest increases in specific cancer risks.